MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 198 filers reported holding MYRIAD GENETICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,256,133 | -34.4% | 701,754 | -5.2% | 0.00% | -50.0% |
| Q2 2023 | $17,157,396 | -2.5% | 740,181 | -2.3% | 0.00% | 0.0% |
| Q1 2023 | $17,605,505 | +49.6% | 757,878 | -6.6% | 0.00% | +33.3% |
| Q4 2022 | $11,770,338 | -26.7% | 811,188 | -3.6% | 0.00% | -25.0% |
| Q3 2022 | $16,055,000 | +7.2% | 841,423 | +2.1% | 0.00% | +33.3% |
| Q2 2022 | $14,981,000 | -35.8% | 824,414 | -11.0% | 0.00% | -40.0% |
| Q1 2022 | $23,335,000 | -9.5% | 925,962 | -0.9% | 0.01% | 0.0% |
| Q4 2021 | $25,783,000 | -13.9% | 934,179 | +0.7% | 0.01% | -16.7% |
| Q3 2021 | $29,939,000 | +9.3% | 927,230 | +3.5% | 0.01% | +20.0% |
| Q2 2021 | $27,387,000 | +0.0% | 895,588 | -0.4% | 0.01% | -16.7% |
| Q1 2021 | $27,377,000 | +54.6% | 899,076 | +0.4% | 0.01% | +50.0% |
| Q4 2020 | $17,705,000 | +44.0% | 895,296 | -5.1% | 0.00% | +33.3% |
| Q3 2020 | $12,297,000 | +14.9% | 942,956 | -0.1% | 0.00% | 0.0% |
| Q2 2020 | $10,707,000 | -16.1% | 944,197 | +5.9% | 0.00% | -25.0% |
| Q1 2020 | $12,763,000 | -49.6% | 891,874 | -4.1% | 0.00% | -42.9% |
| Q4 2019 | $25,336,000 | -11.7% | 930,438 | -7.1% | 0.01% | -12.5% |
| Q3 2019 | $28,681,000 | -1.0% | 1,001,815 | -3.9% | 0.01% | 0.0% |
| Q2 2019 | $28,960,000 | -7.3% | 1,042,497 | +10.7% | 0.01% | -11.1% |
| Q1 2019 | $31,256,000 | +9.1% | 941,433 | -4.5% | 0.01% | 0.0% |
| Q4 2018 | $28,660,000 | -31.5% | 985,904 | +8.3% | 0.01% | -18.2% |
| Q3 2018 | $41,861,000 | +31.2% | 910,032 | +6.6% | 0.01% | +22.2% |
| Q2 2018 | $31,916,000 | +21.3% | 854,058 | -4.1% | 0.01% | +28.6% |
| Q1 2018 | $26,309,000 | -11.1% | 890,323 | +3.4% | 0.01% | -12.5% |
| Q4 2017 | $29,584,000 | -9.9% | 861,378 | -5.0% | 0.01% | -11.1% |
| Q3 2017 | $32,821,000 | +35.8% | 907,166 | -3.0% | 0.01% | +28.6% |
| Q2 2017 | $24,165,000 | +37.1% | 935,217 | +1.8% | 0.01% | +40.0% |
| Q1 2017 | $17,632,000 | +166.3% | 918,305 | +131.2% | 0.01% | +150.0% |
| Q4 2016 | $6,620,000 | -15.1% | 397,159 | +4.9% | 0.00% | 0.0% |
| Q3 2016 | $7,796,000 | -31.5% | 378,779 | +1.8% | 0.00% | -33.3% |
| Q2 2016 | $11,383,000 | -16.9% | 371,972 | +1.6% | 0.00% | -25.0% |
| Q1 2016 | $13,697,000 | -53.5% | 365,953 | -46.4% | 0.00% | -55.6% |
| Q4 2015 | $29,449,000 | +11.5% | 682,356 | -3.1% | 0.01% | +12.5% |
| Q3 2015 | $26,402,000 | +0.1% | 704,439 | -9.2% | 0.01% | +14.3% |
| Q2 2015 | $26,380,000 | +14.1% | 776,121 | +18.8% | 0.01% | +16.7% |
| Q1 2015 | $23,129,000 | +66.7% | 653,384 | +60.4% | 0.01% | +50.0% |
| Q4 2014 | $13,876,000 | -16.6% | 407,384 | -5.5% | 0.00% | -20.0% |
| Q3 2014 | $16,629,000 | -53.7% | 431,160 | -53.2% | 0.01% | 0.0% |
| Q2 2014 | $35,888,000 | +156.1% | 922,140 | +124.9% | 0.01% | +25.0% |
| Q1 2014 | $14,016,000 | +50.3% | 409,945 | -7.8% | 0.00% | +33.3% |
| Q4 2013 | $9,323,000 | -54.7% | 444,421 | -49.3% | 0.00% | 0.0% |
| Q3 2013 | $20,582,000 | +73.6% | 875,840 | +98.5% | 0.00% | -25.0% |
| Q2 2013 | $11,854,000 | – | 441,165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |